RANK ligand inhibition with denosumab for the management of osteoporosis.
about
Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysisLabisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model.Antibody-based therapies in multiple myelomaThe evolving biology and treatment of prostate cancer.Approach to the prostate cancer patient with bone diseaseDenosumab in osteoporosis and oncology.State of the art in anti-cancer mAbs.Denosumab--an emerging treatment for postmenopausal osteoporosis.Denosumab for the management of bone disease in patients with solid tumors.Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.The association between systemic sclerosis and bone mineral density- a meta-analysis of observational studies.Rheumatoid Arthritis: A Complication of Aromatase Inhibitor Therapy?
P2860
Q28242783-2B822FA5-089E-4CEC-B87E-6F231BCE33A6Q34978861-AEFA3B54-B884-447A-9441-52EACEC6FC7AQ35431150-69C62585-3CD5-4C3F-805C-28BF4D125266Q35951473-6DCEC366-85B4-4E6E-BDEE-365229128F60Q36360754-EAA154E7-8C3F-4C33-A3D5-B18AAE3D5F12Q37557994-9793919A-9EAF-4990-9253-C0FA27CB2FDFQ37655585-15F48658-226E-4DE3-BF17-C7DBD8FF8D20Q37679921-B8267160-6212-4C03-BF9D-6F2654F73FA4Q37970800-4C96FCB3-965E-4DA1-9845-4F5B8D1AC0B0Q39091651-A1D36DB4-A0AE-4DC7-BD7E-20071A33F202Q39223387-46BE0C78-510B-4633-A5CA-15F072FDC5C4Q45268266-77A5A633-1C0D-46C0-BC5F-BB4083CDF0D7Q57821320-53CFBFDB-21B8-4D3B-ADDF-699C7272D2F8
P2860
RANK ligand inhibition with denosumab for the management of osteoporosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
RANK ligand inhibition with denosumab for the management of osteoporosis.
@ast
RANK ligand inhibition with denosumab for the management of osteoporosis.
@en
type
label
RANK ligand inhibition with denosumab for the management of osteoporosis.
@ast
RANK ligand inhibition with denosumab for the management of osteoporosis.
@en
prefLabel
RANK ligand inhibition with denosumab for the management of osteoporosis.
@ast
RANK ligand inhibition with denosumab for the management of osteoporosis.
@en
P2860
P1476
RANK ligand inhibition with denosumab for the management of osteoporosis.
@en
P2093
E Michael Lewiecki
P2860
P304
P356
10.1517/14712598.6.10.1041
P407
P577
2006-10-01T00:00:00Z